Poloxamer 217 F77 is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 6600. Poloxamer 217 F77 inhibits proliferation of human lymphocyte cell IIBR1[1].

Poloxamer 234 P84 is is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 4200. Poloxamer 234 P84 forms thermoreversible hydrogel, that is utilized in food additives, drug delivery carriers in cosmetics, pharmaceutical ingredients and tissue engineering[1].

Poloxamer 235 P85 is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 4600. Poloxamer 235 P85 exhibits acute and subchronic toxicity in albino rats with an oral LD50 of >34.6 g/kg. Poloxamer 235 P85 induces ocular irritation in rabbits[1].

Poloxamer 238 F88 is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 11400. Poloxamer 238 F88 reduces the aggregation of red blood cells. Poloxamer 238 F88 forms thermoreversible hydrogel, that is utilized in food additives, drug delivery carriers in cosmetics, pharmaceutical ingredients and tissue engineering[1][2].

Poloxamer 288 F98 is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 13000. Poloxamer 288 F98 reduces the aggregation of red blood cells[1].

Poloxamer 333 P103 is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 4950. Poloxamer 333 P103 exhibits antimicrobial activity, that inihibits 90% Mycobacterium avium complex at concentration of 1 mg/mL. Poloxamer 333 P103 forms thermoreversible hydrogel, that is utilized in food additives, drug delivery carriers in cosmetics, pharmaceutical ingredients and tissue engineering[1][2].

Poloxamer 334 P104 is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 5900. Poloxamer 334 P104 forms thermoreversible hydrogel, that is utilized in food additives, drug delivery carriers in cosmetics, pharmaceutical ingredients and tissue engineering[1].

Poloxamer 335 P105 is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 6500. Poloxamer 335 P105 exhibits antimicrobial activity, that inihibits 86% Mycobacterium avium complex at concentration of 1 mg/mL. Poloxamer 334 P104 exhibits muscular toxicity. Poloxamer 334 P104 forms thermoreversible hydrogel, that is utilized in food additives, drug delivery carriers in […]

Poloxamer 338 F108 is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 14600. Poloxamer 338 F108 reduces the aggregation of red blood cells, inhibits proliferation of human lymphocyte cell IIBR1. Poloxamer 338 F108 exhibits short-term and subchronic toxicity in rats[1][2].

Poloxamer 401 L121 is block polymer of polyoxyethylene and polyoxypropylene. Poloxamer 401 L121 is utilized as lymphotrophic particles in nanoparticle engineering, as inhibitor of multidrug resistance and adjuvant activities or as surfactants and emulsifying agents in cosmetics[1].

Poloxamer 402 L122 (PEG-PPG-PEG, 5000 Averag) is a synthetic triblock copolymer of poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) (PEO-PPO-PEO). Poloxamer 402 L122 forms thermoreversible gel, which remains fluid at room temperature but becomes more viscous gel at body temperature. Poloxamer 402 L122 is utilized in drug delivery, tissue regeneration and generation of micellar system[1].

Poloxamer 403 P123 is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 5750. Poloxamer 403 P123 exhibits muscular toxicity[1].

POLQ Human Pre-designed siRNA Set A contains three designed siRNAs for POLQ gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR1A Human Pre-designed siRNA Set A contains three designed siRNAs for POLR1A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR1B Human Pre-designed siRNA Set A contains three designed siRNAs for POLR1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR1C Human Pre-designed siRNA Set A contains three designed siRNAs for POLR1C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR1D Human Pre-designed siRNA Set A contains three designed siRNAs for POLR1D gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR1E Human Pre-designed siRNA Set A contains three designed siRNAs for POLR1E gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR2A Human Pre-designed siRNA Set A contains three designed siRNAs for POLR2A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR2B Human Pre-designed siRNA Set A contains three designed siRNAs for POLR2B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR2C Human Pre-designed siRNA Set A contains three designed siRNAs for POLR2C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR2D Human Pre-designed siRNA Set A contains three designed siRNAs for POLR2D gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR2E Human Pre-designed siRNA Set A contains three designed siRNAs for POLR2E gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR2F Human Pre-designed siRNA Set A contains three designed siRNAs for POLR2F gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR2G Human Pre-designed siRNA Set A contains three designed siRNAs for POLR2G gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR2H Human Pre-designed siRNA Set A contains three designed siRNAs for POLR2H gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR2I Human Pre-designed siRNA Set A contains three designed siRNAs for POLR2I gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR2J Human Pre-designed siRNA Set A contains three designed siRNAs for POLR2J gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR2J3 Human Pre-designed siRNA Set A contains three designed siRNAs for POLR2J3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR2K Human Pre-designed siRNA Set A contains three designed siRNAs for POLR2K gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR2L Human Pre-designed siRNA Set A contains three designed siRNAs for POLR2L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR3A Human Pre-designed siRNA Set A contains three designed siRNAs for POLR3A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR3B Human Pre-designed siRNA Set A contains three designed siRNAs for POLR3B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR3C Human Pre-designed siRNA Set A contains three designed siRNAs for POLR3C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR3D Human Pre-designed siRNA Set A contains three designed siRNAs for POLR3D gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR3F Human Pre-designed siRNA Set A contains three designed siRNAs for POLR3F gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR3G Human Pre-designed siRNA Set A contains three designed siRNAs for POLR3G gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR3H Human Pre-designed siRNA Set A contains three designed siRNAs for POLR3H gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLR3K Human Pre-designed siRNA Set A contains three designed siRNAs for POLR3K gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLRMT Human Pre-designed siRNA Set A contains three designed siRNAs for POLRMT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Poly-L-lysine Methacryloyl (PLMA) is methacrylated polylysine. When Poly-L-lysine Methacryloyl is cross-linked on polyetheretherketone (PEEK) through UV-induced cross-linking, it can improve the hydrophilicity of PEEK and retain its own degradation bioinertness[1].

Poly-L-ornithine (hydrobromide) (MW 30000-70000) (L-Ornithine homopolymer (hydrobromide) (MW 30000-70000)) is a biochemical reagent that can be used as a biological material or organic compound for life science related research[1].

Poly-L-ornithine (hydrobromide) (MW 5000-15000) (L-Ornithine homopolymer (hydrobromide) (MW 5000-15000)) is a biochemical reagent that can be used as a biological material or organic compound for life science related research[1].

Poly-L-ornithine (hydrochloride) (MW 15000-30000) (L-Ornithine homopolymer (hydrochloride) (MW 15000-30000)) is a biochemical reagent that can be used as a biological material or organic compound for life science related research[1].

Poly(tetrafluoroethylene) (Fluorinated polymer; Fluoropolymer; PTFE) is a biochemical reagent that can be used as a biological material or organic compound for life science related research[1].

Poly(tetrafluoroethylene) (Fluorinated polymer; Fluoropolymer; PTFE) is a biochemical reagent that can be used as a biological material or organic compound for life science related research[1].

Polyacrylamide,Anion,Mw 10-12 million (PAM,Anion,Mw 10-12 million) is a biochemical reagent that can be used as a biological material or organic compound for life science related research[1].

Polyacrylamide,Anion,Mw 14-16 million (PAM,Anion,Mw 14-16 million) is a biochemical reagent that can be used as a biological material or organic compound for life science related research[1].

Polycarpine hydrochloride (1a) is a broad-spectrum Mpro inhibitor (IC50 = 30 nM) that can be isolated from the Polycarpa aurata and also serves as an anti-coronaviral agent. Polycarpine hydrochloride possesses antiviral and antifungal activities, with IC50 values of 30.0 nM and 0.12 μM against SARS-CoV-2 Mpro and PEDV Mpro, respectively[1].